Nuvalent, Inc. (NUVL) Social Stream



Nuvalent, Inc. (NUVL): $16.09

0.21 (+1.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NUVL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Nuvalent Inc (NUVL) Price Targets From Analysts

Use the tables below to see what analysts covering Nuvalent Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $42 $35 $38.5 $15.07 155.47%
2022-03-29 3 $42 $38 $40 $15.07 165.43%
2022-03-31 3 $42 $31 $36.5 $15.07 142.2%

The Trend in the Analyst Price Target


Over the past 140 days, NUVL's average price target has gone down $3.5.

NUVL reports an average of 59.32% for its upside potential over the past 30 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-18 NA 42 42 42.0 36.48 15.13%
2021-09-24 3 42 35 38.5 22.86 68.42%
2021-11-11 3 42 38 40.0 27.20 47.06%
2022-03-29 3 42 38 40.0 13.21 202.8%
2022-03-31 3 42 31 36.5 13.89 162.78%

NUVL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Nuvalent Inc's number of analysts covering the stock is greater than 33.42% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Nuvalent Inc's upside potential (average analyst target price relative to current price) is greater than 255.64% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Nuvalent Inc's variance in analysts' estimates is lower than 54.94% of them.
  • NUVL has a greater average analyst price target than 237.68% of stocks in the small market cap category.

Stocks similar to Nuvalent Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NRXP, NRIX, and NOVN.

Is NUVL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4551 seconds.